Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Reinisch

Showing results (31-40 of 352) with videos related to

Pageof 36
Sort By:
Expert Review of Clinical Immunology|May 13, 2014
Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial targetMariangela Allocca, Gionata Fiorino, Severine Vermeire, et al.
The American Journal of Gastroenterology|July 18, 2023
P010 Precision Dosing Tool Forecasts Trough Infliximab and Associates With Disease Status in Inflammatory Bowel DiseasesThierry Dervieux, Christian Primas, John Panetta, et al.
European Journal of Gastroenterology & Hepatology|March 25, 2024
Comparing the efficacy of vedolizumab between males and females: a post-hoc analysis of GEMINI-1 and VARSITYTarun Chhibba, Emily C L Wong, Walter Reinisch, et al.
European Radiology|May 28, 2008
Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopyJohannes Sailer, Philipp Peloschek, Walter Reinisch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2018
Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysisNeeraj Narula, Abdul-Aziz Alshahrani, Yuhong Yuan, et al.
Inflammatory Bowel Diseases|April 4, 2014
AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled studyWalter Reinisch, Simon Travis, Stephen Hanauer, et al.
Inflammatory Bowel Diseases|January 13, 2017
The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel DiseaseJames D Lewis, Lindsey Albenberg, Dale Lee, et al.
Crohn'S & Colitis 360|September 11, 2023
Low Occurrence of Colectomy With Long-Term (up to 4 Years) Golimumab Treatment in Patients With Moderate-to-Severe Active Ulcerative Colitis: Data From the PURSUIT Maintenance and Long-Term Extension StudiesCindy L J Weinstein, Alan G Meehan, Marinella Govoni, et al.
Journal of Clinical Pharmacology|September 9, 2020
Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody DetectionAlexander Eser, Walter Reinisch, Stefan Schreiber, et al.
European Journal of Gastroenterology & Hepatology|September 27, 2022
Pilot study of an elimination diet in adults with mild to moderate Crohn's diseaseNeeraj Narula, Emily C L Wong, Paul Moayyedi, et al.
Pageof 36

Showing results (31-40 of 352) with videos related to

Sort By:
Pageof 36
Expert Review of Clinical Immunology|May 13, 2014
Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial targetMariangela Allocca, Gionata Fiorino, Severine Vermeire, et al.
The American Journal of Gastroenterology|July 18, 2023
P010 Precision Dosing Tool Forecasts Trough Infliximab and Associates With Disease Status in Inflammatory Bowel DiseasesThierry Dervieux, Christian Primas, John Panetta, et al.
European Journal of Gastroenterology & Hepatology|March 25, 2024
Comparing the efficacy of vedolizumab between males and females: a post-hoc analysis of GEMINI-1 and VARSITYTarun Chhibba, Emily C L Wong, Walter Reinisch, et al.
European Radiology|May 28, 2008
Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopyJohannes Sailer, Philipp Peloschek, Walter Reinisch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2018
Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysisNeeraj Narula, Abdul-Aziz Alshahrani, Yuhong Yuan, et al.
Inflammatory Bowel Diseases|April 4, 2014
AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled studyWalter Reinisch, Simon Travis, Stephen Hanauer, et al.
Inflammatory Bowel Diseases|January 13, 2017
The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel DiseaseJames D Lewis, Lindsey Albenberg, Dale Lee, et al.
Crohn'S & Colitis 360|September 11, 2023
Low Occurrence of Colectomy With Long-Term (up to 4 Years) Golimumab Treatment in Patients With Moderate-to-Severe Active Ulcerative Colitis: Data From the PURSUIT Maintenance and Long-Term Extension StudiesCindy L J Weinstein, Alan G Meehan, Marinella Govoni, et al.
Journal of Clinical Pharmacology|September 9, 2020
Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody DetectionAlexander Eser, Walter Reinisch, Stefan Schreiber, et al.
European Journal of Gastroenterology & Hepatology|September 27, 2022
Pilot study of an elimination diet in adults with mild to moderate Crohn's diseaseNeeraj Narula, Emily C L Wong, Paul Moayyedi, et al.
Pageof 36